Associate Clinical Professor of Psychiatry, Massachusetts General Hospital
Psychiatry
Dr. Gary S. Sachs, MD
|
|
Give Review
Gary Sachs is an expert in the field of Psychiatry. He studied medicine at University of Maryland School of Medicine. University of Maryland School of Medicine has a rank of 37 in research and a 52 in primary care Gary S. Sachs is also a published doctor. He has 73 paper published. The most recent paper is: The Bipolarity index: a clinician-rated measure of diagnostic confidence.
Publications
- The Bipolarity index: a clinician-rated measure of diagnostic confidence.
- Update on best practices for managing bipolar depression.
- Polypharmacy and bipolar disorder: what's personality got to do with it?
- Unmet needs in the assessment and management of bipolar I depression.
- Association Between Therapeutic Alliance, Care Satisfaction, and Pharmacological Adherence in Bipolar Disorder.
- Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
- Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal dete...
- Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial out...
- Sleep disturbance in euthymic bipolar patients.
- Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles.
- Sleep matters: Sleep functioning and course of illness in bipolar disorder.
- Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlle...
- The pharmacologic treatment of bipolar disorder.
- Longitudinal Follow-Up of Bipolar Disorder in Women With Premenstrual Exacerbation: Findings From STEP-BD.
- Transition to mania during treatment of bipolar depression.
- Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.
- Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term ...
- Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study.
- Assuring that double-blind is blind.
- Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.
- Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder.
- Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus.
- A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.
- Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD.
- Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD.
- Increased rate of non-right-handedness in patients with bipolar disorder.
- Psychosocial interventions as adjunctive therapy for bipolar disorder.
- The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD.
- Correlates of functioning in bipolar disorder.
- Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
- Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
- Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.
- Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline.
- Effectiveness of adjunctive antidepressant treatment for bipolar depression.
- Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.
- Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder.
- Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report.
- The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder.
- Update on bipolar disorder and substance abuse: recent findings and treatment strategies.
- Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder.
- Psychosocial strategies to improve concordance and adherence in bipolar disorder.
- Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder.
- Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
- Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder.
- Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy...
- Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
- Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
- Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.
- Implementing evidence-based treatment of manic and mixed episodes.
- A review of agitation in mental illness: burden of illness and underlying pathology.
- Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for ...
- The integration of measurement and management for the treatment of bipolar disorder: a STEP-BD model of collaborative care in psychiatry.
- Predictors of bipolar disorder risk among patients currently treated for major depression.
- Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD.
- Suicidal ideation and pharmacotherapy among STEP-BD patients.
- Contributors to suicidal ideation among bipolar patients with and without a history of suicide attempts.
- Focus on bipolar disorder treatment.
- Psychopathology in the offspring of parents with bipolar disorder: a controlled study.
- Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
- Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (S...
- Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program.
- Presence of irritability during depressive episodes in bipolar disorder.
- Do antidepressants induce rapid cycling? A gender-specific association.
- Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach.
- Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
- Unmet clinical needs in bipolar disorder.
- Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals?
- Decision tree for the treatment of bipolar disorder.
- Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.
- Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data.
- Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
- Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Schools
University of Maryland At Baltimore Professional Schools
University MD Hospital
Massachusetts General Hospital
Doctors Specialties
- Psychiatry
Accepted Insurances
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
Education
-
Massachusetts General Hospital -
University of Maryland -
University of Maryland School of Medicine
Hospital
-
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Ottavio V. Vitolo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olivia I. Okereke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Siu P. Chin Feman, MD |
|
|
Dr. James M. Wilkins, MD |
|
|
Dr. Brian J. Schulman, MD |
|
|
Dr. David Medoff, PHD |
|
|
Dr. Sarah E. Rocha, MD |
|
|
Dr. Shirali S. Patel, MD |
|
|
Dr. Benjamin Brent, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hector Colon Rivera, MD |
|
|
Dr. Jessica M. Yeatermeyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert D. Mendenhall, MD |